Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Aug 27, 2023; 15(8): 1728-1738
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1728
Table 1 Comparison of general data of two groups, n (%)
General information
Control group (n = 57)
Observation group (n = 63)
χ2/t
P value
Gender0.0630.802
Male41 (71.93)44 (69.84)
Female16 (28.07)19 (30.16)
Age [ (mean ± SD), age]57.79 ± 9.2856.70 ± 11.270.570.57
BMI [ (mean ± SD), kg/m2]23.43 ± 3.7323.17 ± 3.060.4330.666
Type of disease0.020.887
Rectal cancer21 (36.84)24 (38.10)
Colon cancer36 (63.16)39 (61.90)
Maximum diameter of metastatic lesion [(mean ± SD), cm]3.46 ± 0.943.39 ± 0.980.3980.691
Number of liver metastatic lesions
120 (35.09)23 (36.51)0.0360.982
219 (33.33)21 (33.33)
≥ 318 (31.58)19 (30.16)
Surgical program [n (%)]0.30.956
Partial hepatectomy21 (36.84)24 (38.10)
Segmentectomy16 (28.07)15 (23.81)
Lobectomy14 (24.56)17 (26.98)
Other6 (10.53)7 (11.11)